Compendium of Polycystic Ovarian Syndrome and Its Relevance in Glycation and Diabetes
January 2022
in “
Journal of experimental and clinical medicine
”
Polycystic Ovarian Syndrome Type 2 Diabetes Mellitus insulin resistance advanced glycation end products receptors for advanced glycation end products M. oleifera S. platensis metformin inositol thiazolidinediones spironolactone hormonal imbalances metabolic dysfunctions PCOS T2DM IR AGEs RAGE moringa spirulina
Studysummary This review examines the relationship between glycation, insulin resistance, and PCOS, discussing various treatments and highlighting M. oleifera and S. platensis as potential therapeutic agents, but reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Polycystic Ovarian Syndrome (PCOS) is closely linked with metabolic disorders such as Type 2 Diabetes Mellitus (T2DM), with insulin resistance (IR) being a central factor. The review highlights the connection between PCOS, IR, and the formation of advanced glycation end products (AGEs), which contribute to IR and can worsen PCOS and diabetes symptoms. It suggests that targeting the interaction between AGEs and their receptors (RAGE) may help in managing IR-related complications. The document also discusses the potential benefits of M. oleifera and S. platensis in providing symptomatic relief for PCOS and mentions common medications like metformin, inositol, thiazolidinediones, and spironolactone used for treatment. The review underscores the complex relationship between hormonal imbalances and metabolic dysfunctions in PCOS.
